Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Halstenson

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 1986
Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysisK L Heim, C E Halstenson, C M Comty, et al.
American Journal of Nephrology|January 1, 1985
Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipientsD B Haughey, C J Kraft, G R Matzke, et al.
American Journal of Nephrology|January 1, 1988
Suprofen-induced uricosuria. A potential mechanism for acute nephropathy and flank painP A Abraham, C E Halstenson, J A Opsahl, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1987
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitisG R Matzke, C E Halstenson, P L Olson, et al.
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1994
Evaluation of two intravenous single-bolus methods for measuring effective renal plasma flowC A Hirata-Dulas, W M Awni, G R Matzke, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1990
Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal diseaseC E Halstenson, C A Hirata, K L Heim-Duthoy, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effect of haemodialysis on the pharmacokinetics of cetirizineW M Awni, J Yeh, C E Halstenson, et al.
The Annals of Pharmacotherapy|April 1, 1997
Absolute bioavailability of bromfenac in humansK Gumbhir-Shah, W H Cevallos, S A DeCleene, et al.
Journal of Clinical Pharmacology|April 1, 1990
Pharmacokinetics of loratadine in patients with renal insufficiencyG R Matzke, C E Halstenson, J A Opsahl, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|July 1, 1986
Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysisK L Heim, C E Halstenson, C M Comty, et al.
American Journal of Nephrology|January 1, 1985
Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipientsD B Haughey, C J Kraft, G R Matzke, et al.
American Journal of Nephrology|January 1, 1988
Suprofen-induced uricosuria. A potential mechanism for acute nephropathy and flank painP A Abraham, C E Halstenson, J A Opsahl, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1987
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitisG R Matzke, C E Halstenson, P L Olson, et al.
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1994
Evaluation of two intravenous single-bolus methods for measuring effective renal plasma flowC A Hirata-Dulas, W M Awni, G R Matzke, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1990
Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal diseaseC E Halstenson, C A Hirata, K L Heim-Duthoy, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effect of haemodialysis on the pharmacokinetics of cetirizineW M Awni, J Yeh, C E Halstenson, et al.
The Annals of Pharmacotherapy|April 1, 1997
Absolute bioavailability of bromfenac in humansK Gumbhir-Shah, W H Cevallos, S A DeCleene, et al.
Journal of Clinical Pharmacology|April 1, 1990
Pharmacokinetics of loratadine in patients with renal insufficiencyG R Matzke, C E Halstenson, J A Opsahl, et al.
Pageof 9